The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension

J. E. Sealey, N. Von Lutterotti, S. Rubattu, W. G. Campbell, F. Gahnem, J. M. Halimi, J. H. Laragh

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A greater renin system is proposed. Evidence is presented that a greater renin system exists that has both vasodilator and vasoconstrictor properties. Vasodilator activity is induced by prorenin, vasoconstrictor activity by renin. Our model is based on evidence that both prorenin and renin have the capacity to generate angiotensin and that angiotensin causes vasodilation at high concentrations and vasoconstriction at low concentrations. In our model, prorenin acts only at particular target sites while renin of renal origin acts via the general circulation. Prorenin's designation as a biosynthetic precursor implies lack of intrinsic catalytic activity whereas in fact it can become reversibly active. Activation may occur in vivo at binding sites without cleavage of the prosequence. In this framework, prorenin should be more aptly called renin I and circulating active renin, renin II. In our model, the role of renin I (prorenin) is to generate localized high concentrations of angiotensin II, eg, in the afferent arteriole of the kidney and in other vital organs, causing regional dilation by rendering tissues insensitive (tachyphylactic) to the vasoconstrictor effect of circulating angiotensin II or by releasing vasodilator substances. The role of renin II (active renin) is to constrict resistance vessels and the efferent arteriole of the kidney, therapy raising blood pressure, maintaining glomerular filtration rate, and enabling more blood flow to those organs that selectively bind prorenin. This twin control system is ideally designed to maintain blood flow to vital organs. Lack of coordination between the limbs of the greater renin system with a relative excess of renin I would explain the relationship of high prorenin levels to the hyperperfusion injury of diabetes mellitus and the devastating effects of hypertension when it occurs in pregnancy. Conversely, a relative excess of renin II would lead to the hypertension and to the ischemic vascular injury of high renin hypertensive disorders. New research will define, extend, or disprove this concept of a greater renin system. Meanwhile, it is consistent with the experimental evidence concerning tissue renin and the renal-endocrine circulating renin system.

Original languageEnglish
Pages (from-to)972-977
Number of pages6
JournalAmerican Journal of Hypertension
Volume4
Issue number12 I
Publication statusPublished - 1991

Fingerprint

Vasodilator Agents
Renin
Diabetes Mellitus
Extremities
Hypertension
Pregnancy
Vasoconstrictor Agents
Kidney
Angiotensins
Arterioles
Angiotensin II

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sealey, J. E., Von Lutterotti, N., Rubattu, S., Campbell, W. G., Gahnem, F., Halimi, J. M., & Laragh, J. H. (1991). The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension. American Journal of Hypertension, 4(12 I), 972-977.

The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension. / Sealey, J. E.; Von Lutterotti, N.; Rubattu, S.; Campbell, W. G.; Gahnem, F.; Halimi, J. M.; Laragh, J. H.

In: American Journal of Hypertension, Vol. 4, No. 12 I, 1991, p. 972-977.

Research output: Contribution to journalArticle

Sealey, JE, Von Lutterotti, N, Rubattu, S, Campbell, WG, Gahnem, F, Halimi, JM & Laragh, JH 1991, 'The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension', American Journal of Hypertension, vol. 4, no. 12 I, pp. 972-977.
Sealey, J. E. ; Von Lutterotti, N. ; Rubattu, S. ; Campbell, W. G. ; Gahnem, F. ; Halimi, J. M. ; Laragh, J. H. / The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension. In: American Journal of Hypertension. 1991 ; Vol. 4, No. 12 I. pp. 972-977.
@article{021986696f8444ad9c354a998e74d458,
title = "The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension",
abstract = "A greater renin system is proposed. Evidence is presented that a greater renin system exists that has both vasodilator and vasoconstrictor properties. Vasodilator activity is induced by prorenin, vasoconstrictor activity by renin. Our model is based on evidence that both prorenin and renin have the capacity to generate angiotensin and that angiotensin causes vasodilation at high concentrations and vasoconstriction at low concentrations. In our model, prorenin acts only at particular target sites while renin of renal origin acts via the general circulation. Prorenin's designation as a biosynthetic precursor implies lack of intrinsic catalytic activity whereas in fact it can become reversibly active. Activation may occur in vivo at binding sites without cleavage of the prosequence. In this framework, prorenin should be more aptly called renin I and circulating active renin, renin II. In our model, the role of renin I (prorenin) is to generate localized high concentrations of angiotensin II, eg, in the afferent arteriole of the kidney and in other vital organs, causing regional dilation by rendering tissues insensitive (tachyphylactic) to the vasoconstrictor effect of circulating angiotensin II or by releasing vasodilator substances. The role of renin II (active renin) is to constrict resistance vessels and the efferent arteriole of the kidney, therapy raising blood pressure, maintaining glomerular filtration rate, and enabling more blood flow to those organs that selectively bind prorenin. This twin control system is ideally designed to maintain blood flow to vital organs. Lack of coordination between the limbs of the greater renin system with a relative excess of renin I would explain the relationship of high prorenin levels to the hyperperfusion injury of diabetes mellitus and the devastating effects of hypertension when it occurs in pregnancy. Conversely, a relative excess of renin II would lead to the hypertension and to the ischemic vascular injury of high renin hypertensive disorders. New research will define, extend, or disprove this concept of a greater renin system. Meanwhile, it is consistent with the experimental evidence concerning tissue renin and the renal-endocrine circulating renin system.",
author = "Sealey, {J. E.} and {Von Lutterotti}, N. and S. Rubattu and Campbell, {W. G.} and F. Gahnem and Halimi, {J. M.} and Laragh, {J. H.}",
year = "1991",
language = "English",
volume = "4",
pages = "972--977",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "12 I",

}

TY - JOUR

T1 - The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension

AU - Sealey, J. E.

AU - Von Lutterotti, N.

AU - Rubattu, S.

AU - Campbell, W. G.

AU - Gahnem, F.

AU - Halimi, J. M.

AU - Laragh, J. H.

PY - 1991

Y1 - 1991

N2 - A greater renin system is proposed. Evidence is presented that a greater renin system exists that has both vasodilator and vasoconstrictor properties. Vasodilator activity is induced by prorenin, vasoconstrictor activity by renin. Our model is based on evidence that both prorenin and renin have the capacity to generate angiotensin and that angiotensin causes vasodilation at high concentrations and vasoconstriction at low concentrations. In our model, prorenin acts only at particular target sites while renin of renal origin acts via the general circulation. Prorenin's designation as a biosynthetic precursor implies lack of intrinsic catalytic activity whereas in fact it can become reversibly active. Activation may occur in vivo at binding sites without cleavage of the prosequence. In this framework, prorenin should be more aptly called renin I and circulating active renin, renin II. In our model, the role of renin I (prorenin) is to generate localized high concentrations of angiotensin II, eg, in the afferent arteriole of the kidney and in other vital organs, causing regional dilation by rendering tissues insensitive (tachyphylactic) to the vasoconstrictor effect of circulating angiotensin II or by releasing vasodilator substances. The role of renin II (active renin) is to constrict resistance vessels and the efferent arteriole of the kidney, therapy raising blood pressure, maintaining glomerular filtration rate, and enabling more blood flow to those organs that selectively bind prorenin. This twin control system is ideally designed to maintain blood flow to vital organs. Lack of coordination between the limbs of the greater renin system with a relative excess of renin I would explain the relationship of high prorenin levels to the hyperperfusion injury of diabetes mellitus and the devastating effects of hypertension when it occurs in pregnancy. Conversely, a relative excess of renin II would lead to the hypertension and to the ischemic vascular injury of high renin hypertensive disorders. New research will define, extend, or disprove this concept of a greater renin system. Meanwhile, it is consistent with the experimental evidence concerning tissue renin and the renal-endocrine circulating renin system.

AB - A greater renin system is proposed. Evidence is presented that a greater renin system exists that has both vasodilator and vasoconstrictor properties. Vasodilator activity is induced by prorenin, vasoconstrictor activity by renin. Our model is based on evidence that both prorenin and renin have the capacity to generate angiotensin and that angiotensin causes vasodilation at high concentrations and vasoconstriction at low concentrations. In our model, prorenin acts only at particular target sites while renin of renal origin acts via the general circulation. Prorenin's designation as a biosynthetic precursor implies lack of intrinsic catalytic activity whereas in fact it can become reversibly active. Activation may occur in vivo at binding sites without cleavage of the prosequence. In this framework, prorenin should be more aptly called renin I and circulating active renin, renin II. In our model, the role of renin I (prorenin) is to generate localized high concentrations of angiotensin II, eg, in the afferent arteriole of the kidney and in other vital organs, causing regional dilation by rendering tissues insensitive (tachyphylactic) to the vasoconstrictor effect of circulating angiotensin II or by releasing vasodilator substances. The role of renin II (active renin) is to constrict resistance vessels and the efferent arteriole of the kidney, therapy raising blood pressure, maintaining glomerular filtration rate, and enabling more blood flow to those organs that selectively bind prorenin. This twin control system is ideally designed to maintain blood flow to vital organs. Lack of coordination between the limbs of the greater renin system with a relative excess of renin I would explain the relationship of high prorenin levels to the hyperperfusion injury of diabetes mellitus and the devastating effects of hypertension when it occurs in pregnancy. Conversely, a relative excess of renin II would lead to the hypertension and to the ischemic vascular injury of high renin hypertensive disorders. New research will define, extend, or disprove this concept of a greater renin system. Meanwhile, it is consistent with the experimental evidence concerning tissue renin and the renal-endocrine circulating renin system.

UR - http://www.scopus.com/inward/record.url?scp=0026337155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026337155&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 972

EP - 977

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 12 I

ER -